CRYSTAL ROGER 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Jan 9, 2023
Insider Transaction Report
Form 4
CRYSTAL ROGER
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2023-01-09$20.20/sh−1,183$23,897→ 76,697 total
Footnotes (1)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.